indazoles has been researched along with transforming growth factor alpha in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 2 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Aharoni-Simon, M; Anavi, S; Beifuss, U; Madar, Z; Tirosh, O | 1 |
| Chang, LH; Lai, CY; Pan, SL; Teng, CM; Tsai, AC | 1 |
2 other study(ies) available for indazoles and transforming growth factor alpha
| Article | Year |
|---|---|
Nitric oxide, can it be only good? Increasing the antioxidant properties of nitric oxide in hepatocytes by YC-1 compound.
Topics: Animals; Antioxidants; Glutathione; Heme Oxygenase-1; Hepatocytes; Humans; Indazoles; Mice; NF-E2-Related Factor 2; Nitric Oxide; Nitroso Compounds; Transforming Growth Factor alpha | 2012 |
Activated PAR-2 regulates pancreatic cancer progression through ILK/HIF-α-induced TGF-α expression and MEK/VEGF-A-mediated angiogenesis.
Topics: Basic Helix-Loop-Helix Transcription Factors; Cell Line, Tumor; Down-Regulation; Flavonoids; Humans; Hypoxia-Inducible Factor 1, alpha Subunit; Indazoles; Mitogen-Activated Protein Kinase Kinases; Neovascularization, Pathologic; Pancreatic Neoplasms; Protein Kinase Inhibitors; Protein Serine-Threonine Kinases; Receptor, PAR-2; RNA, Small Interfering; Signal Transduction; Transforming Growth Factor alpha; Up-Regulation; Vascular Endothelial Growth Factor A | 2013 |